Pell Bio-Med Technology Statistics

Total Valuation

TPE:6949 has a market cap or net worth of TWD 9.37 billion. The enterprise value is 8.80 billion.

Market Cap	9.37B
Enterprise Value	8.80B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPE:6949 has 58.35 million shares outstanding. The number of shares has increased by 18.48% in one year.

Current Share Class	58.35M
Shares Outstanding	58.35M
Shares Change (YoY)	+18.48%
Shares Change (QoQ)	-0.80%
Owned by Insiders (%)	16.77%
Owned by Institutions (%)	n/a
Float	27.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	352.40
PB Ratio	7.67
P/TBV Ratio	8.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-23.17
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.23

Financial Position

The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.29.

Current Ratio	3.23
Quick Ratio	3.18
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-0.62
Interest Coverage	-130.07

Financial Efficiency

Return on equity (ROE) is -29.13% and return on invested capital (ROIC) is -16.11%.

Return on Equity (ROE)	-29.13%
Return on Assets (ROA)	-15.39%
Return on Invested Capital (ROIC)	-16.11%
Return on Capital Employed (ROCE)	-30.30%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	7.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.42%
50-Day Moving Average	137.59
200-Day Moving Average	112.33
Relative Strength Index (RSI)	71.37
Average Volume (20 Days)	119,098

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6949 had revenue of TWD 26.58 million and -379.89 million in losses. Loss per share was -6.56.

Revenue	26.58M
Gross Profit	-5.02M
Operating Income	-409.47M
Pretax Income	-386.31M
Net Income	-379.89M
EBITDA	-390.25M
EBIT	-409.47M
Loss Per Share	-6.56

Full Income Statement

Balance Sheet

The company has 1.03 billion in cash and 357.97 million in debt, giving a net cash position of 667.95 million or 11.45 per share.

Cash & Cash Equivalents	1.03B
Total Debt	357.97M
Net Cash	667.95M
Net Cash Per Share	11.45
Equity (Book Value)	1.22B
Book Value Per Share	19.22
Working Capital	722.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -266.06 million and capital expenditures -311.87 million, giving a free cash flow of -577.93 million.

Operating Cash Flow	-266.06M
Capital Expenditures	-311.87M
Free Cash Flow	-577.93M
FCF Per Share	-9.90

Full Cash Flow Statement

Margins

Gross Margin	-18.90%
Operating Margin	-1,540.75%
Pretax Margin	-1,453.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6949 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.48%
Shareholder Yield	-18.48%
Earnings Yield	-4.06%
FCF Yield	-6.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPE:6949 has an Altman Z-Score of 7.08 and a Piotroski F-Score of 2.

Altman Z-Score	7.08
Piotroski F-Score	2